MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/90/0.1/20.06.25 | Market Closed - Börse Stuttgart 12:21:31 19/06/2024 am IST | ||
| 0.36 EUR | -14.29% |
|
| Current month | +16.67% | ||
| 1 month | +40.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 19/24/19 | 0.36 | -14.29% |
| 17/24/17 | 0.42 | -2.33% |
| 14/24/14 | 0.43 | +2.38% |
| 13/24/13 | 0.42 | -4.55% |
| 12/24/12 | 0.44 | +10.00% |
Delayed Quote Börse Stuttgart
Last update June 19, 2024 at 12:21 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | Morgan Stanley |
| WKN | ME3GY8 |
| ISIN | DE000ME3GY86 |
| Date issued | 13/11/2023 |
| Strike | 90 $ |
| Maturity | 20/06/2025 (367 Days) |
| Parity | 10 : 1 |
| Emission price | 0.2 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.44 € |
|---|---|
| Lowest since issue | 0.056 € |
| Delta | 0.36x |
| Omega | 6.937 |
| Premium | 19.9x |
| Gearing | 19.47x |
| Moneyness | 0.8713 |
| Difference Strike | 11.58 $ |
| Difference Strike % | +12.87% |
| Spread | 0.03 € |
| Spread % | 7.69% |
| Theoretical value | 0.3750 |
| Implied Volatility | 23.85 % |
| Total Loss Probability | 72.06 % |
| Intrinsic value | 0.000000 |
| Present value | 0.3750 |
| Break even | 94.03 € |
| Theta | -0.01x |
| Vega | 0.03x |
| Rho | 0.02x |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
157.5
USD
Average target price
174.4
USD
Spread / Average Target
+10.73%
- Stock Market
- Warrants
- Warrant
